Endothelial dysfunction: Cause of the insulin resistance syndrome

Diabetes

Volumn 46, Issue SUPPL. 2, 1997, Pages

  Pinkney, Jonathan H ^b,d   Stehouwer, Coen D A ^c   Coppack, Simon W ^a   Yudkin, John S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CIGARETTE SMOKING; CONFERENCE PAPER; DYSLIPIDEMIA; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; GLUCOSE INTOLERANCE; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0030884022     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.s9     Document Type: Conference Paper

References (46)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809, 1993
3. Ross R, Glomset J, Harker L: Response to injury and atherogenesis. Am J Pathol 86:675-684, 1977
4. Williams KJ, Tabas I: The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15:551-561, 1995
5. Paleolog EM, Crossman DC, McVey JH, Pearson JD: Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. Blood 75:688-695, 1990
6. Lentz SR, Tsiang M, Sadler JE: Regulation of thrombomodulin by tumour necrosis factor-alpha: comparison of transcriptional and posttranslational mechanisms. Blood 77:542-550, 1991
7. Yamamoto C, Kaji T, Sakamoto M, Kozuka H: Modulation by endothelin-1 of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells: interaction of endothelin-1 with cytokines. Biol Pharm Bull 16:714-715, 1993
8. Bevilacqua MP: Endothelial-leukocyte adhesion molecules. Ann Rev Immunol 11:767-804, 1993
9. DiCorleto PE, Soyombo AA: The role of the endothelium in atherogenesis. Curr Opin Lipidol 4:364-372, 1993
10. Malek AM, Jackman R, Rosenberg RD, Izumo S: Endothelial expression of thrombomodulin is reversibly regulated by fluid shear stress. Circ Res 74:852-860, 1994
11. Blann AD, Naqvi T, Waite M, McCollum CN: Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 7:107-111, 1993
12. Schmitz A, Ingerslev J: Haemostatic measures in type 2 diabetic patients with microalbuminuria. Diabetic Med 7:521-525, 1990
13. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V: Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 344:14-18, 1994
14. Blann AD: Increased circulating levels of von Willebrand Factor antigen in smokers may be due to lipid peroxides. Med Sci Res 19:535-536, 1991
15. Seigneur M, Dufourcq P, Conri C, Constans J, Mercie P, Pruvost P, Amiral J, Midy D, Baste JC, Biosseau MR: Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 71:423-431, 1993
16. Healy B: Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. J Am Coll Cardiol 16:357-358, 1990
17. Reymer PWA, Gagne E, Groenemayer BE, Zhang H, Forsyth I, Jansen H, Seidell JC, Krombout D, Lie KE, Kastelein J, Hayden MR: A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet 10:28-30, 1995
18. Vane JR, Angaard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 323:27-36, 1990
19. Dzau VJ, Gibbons GH: Endothelium and growth factors in vascular remodeling of hypertension. Hypertension 18:III-115-III-121, 1991
20. Juhan-Vague I, Thompson SG, Jespersen J: Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris. Arterioscler Thromb 13:1865-1873, 1993
21. Schneider DJ, Nordt TK, Sobel BE: Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 42:1-7, 1993
22. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G: Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41:736-741, 1992
23. Jarret RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin dependent diabetes. Diabetic Med 1:17-19, 1984
24. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet ii:530-533, 1988
25. Nosadini R, Cipollina MR, Solini A, Sambataro M, Morucutti M, Doria A, Fioretto P, Brocco E, Muollo B, Frigato F: Close relationships between microalbuminuria and insulin resistance in essential hypertension and non-insulin dependent diabetes mellitus. J Am Soc Nephrol 2:S56-S63, 1992
26. Groop L, Ekstrand A, Forsblom C, Widen E, Groop P, Teppo A, Eriksson J: Insulin resistance, hypertension, and microalbuminuria in patients with type 2 (non-insulindependent) diabetes mellitus. Diabetologia 36:642-647, 1993
27. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti GC: Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342:883-887, 1993
28. Stehouwer CDA, Fischer A, van Kuijk AWR, Polak BCP, Donker AJM: Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 44:561-564, 1995
29. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340:319-323, 1992
30. Baron AD: Cardiovascular actions of insulin in humans: implications for insulin sensitivity and vascular tone. In Anonymous Insulin Resistance. Ferrannini E, Ed. London, Bailliere Tindall, 1994, p. 961-985
31. Lulloja S, Young AA, Culter CL, Ivy JL, Abbott WGH, Zawadski JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C: Skeletal muscle capillary density and fiber type are possible determinants of in-vivo insulin resistance in man. J Clin Invest 80:415-424, 1987
32. Lithell H, Lindgarde F, Hellsing K, Lundqvist G, Nygaard E, Vessby B, Saltin B: Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year-old men. Diabetes 30:19-25, 1981
33. Jansson PE, Fowelin JP, Von Schenk HP, Smith UP, Lonnroth PN: Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Diabetes 42:1469-1473, 1993
34. Yang YJ, Hope ID, Ader M, Bergman R: Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 84:1620-1628, 1989
35. Castillo C, Bogardus C, Bergman R, Thuillez P, Lillioja S: Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. J Clin Invest 93:10-16, 1994
36. Miles PDG, Levisetti M, Reichart D, Khoursheed M, Moossa AR, Olefsky JM: Kinetics of insulin action in vivo: identification of rate limiting steps. Diabetes 44:947-953, 1995
37. Blann AD, McCollum CN: Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 70:707-711, 1993
38. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88:2149-2155, 1992
39. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YI, Reaven GM: Insulin resistance and cigarette smoking. Lancet 339:1128-1130, 1992
40. Axelsen M, Eliasson B, Joheim E, Lenner RA, Taskinen M, Smith U: Lipid intolerance in smokers. J Intern Med 237:449-455, 1995
41. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992
42. Williams SA, Boolell M, MacGregor GA, Smaje LH, Wasserman SM, Tooke JE: Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension. Clin Sci 79:5-8, 1990
43. Tooke JE: Microvascular function in human diabetes: a physiological perspective. Diabetes 44:721-726, 1995
44. Juhan-Vague I, Thompson SG, Jespersen J, on behalf of the ECAT Angina Pectoris Study Group: Involvement of the hemostatic system in the insulin resistance syndrome. Arterioscler Thromb 13:1865-1873, 1993
45. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 70:380-385, 1993
46. Heine RJ, Home PD, Poncher M, Orskov H, Hammond V, McCulloch AJ, Hanning I, Alberti KGMM: A comparison of 3 methods for assessing insulin sensitivity in subjects with normal and abnormal glucose tolerance. Diabetes Res 2:113-120, 1985